ReviewToxics2025
Biomonitoring of Environmental Phenols, Phthalate Metabolites, Triclosan, and Per- and Polyfluoroalkyl Substances in Humans with Chromatography and Mass Spectrometry.
Review in Toxics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Review
- Column switching liquid chromatography dual mass spectrometry system for simultaneous untargeted metabolomics and targeted exposomics.Nature communications · 2026Article
- Genetic Polymorphisms as Key Modulators of Cardiovascular Risk from Endocrine-Disrupting Chemicals.Genes · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
Endocrine-disrupting chemicals (EDCs) are widespread organic compounds that interfere with hormone signaling and are linked to reproductive, developmental, cardiovascular, and cancer-related health effects. Key EDCs include bisphenol-A and its analogs, phthalates, parabens, triclosan, and per-and polyfluoroalkyl substances (PFAS), which are commonly present in personal care products and plastics. Human exposure occurs via environmental exposure through ingestion, inhalation, and dermal contact, with persistent compounds such as PFAS accumulating in blood, while others are excreted in urine as free or conjugated metabolites. Accurate assessment of EDC exposure, particularly during pregnancy and early childhood, requires robust analytical methods. Liquid and gas chromatography coupled with mass spectrometry (LC-MS and GC-MS) are the most widely used techniques to date. LC-MS is favored for its sensitivity, specificity, and minimal sample preparation, whereas GC-MS provides adequate performance but often requires time-consuming derivatization. This review summarizes current LC-MS and GC-MS methodologies for multi-class EDC biomonitoring, emphasizing sample preparation, analyte coverage, and methodological strengths and limitations, providing a practical reference for human exposure studies using common biological matrices such as urine and blood.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.